Skip to main content
INBX logo

INBX · Inhibrx Biosciences, Inc. · Analyst Estimates

Track INBX — free
$112.04 +2.69 (+2.46%)
Market Cap
$1.54B
Shares
14.72M

Analyst Estimates

Compare analyst forecasts for Inhibrx Biosciences, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-20 08:41 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-9.58
-9.255
-8.93
-9.26
-9.26
-9.255
-9.26
EPS
analysts
Publication date not stated
2
1
1
0
0
Revenue
USD
Publication date not stated
0
0
0
Revenue
analysts
Publication date not stated
3

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-9.05
-8.76
-8.47
-6.3
-6.3
-8.76
-6.3
EPS
analysts
Publication date not stated
2
1
1
0
0
Revenue
USD
Publication date not stated
23903000
36051000
54050000
Revenue
analysts
Publication date not stated
3

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.57
-2.355
-2.14
-2.39
-2.39
-2.355
-2.39
EPS
analysts
Publication date not stated
2
1
1
0
0
Revenue
USD
Publication date not stated
0
0
0
Revenue
analysts
Publication date not stated
3

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.53
-2.415
-2.3
-2.45
-2.45
-2.415
-2.45
EPS
analysts
Publication date not stated
2
1
1
0
0
Revenue
USD
Publication date not stated
0
0
0
Revenue
analysts
Publication date not stated
3
Key facts CIK 2007919 CUSIP 45720N103 13F (30d) 4 filings 4 filers Visit website Investor relations